Bayer AG CEO Eyes Falling Profit Margins in Drugs, Plastics

Bayer expects to see falling profit margins in drugs and plastics as the euro debt crisis sends tremors through economy, chief executive Marijn Dekkers told a German newspaper. "There is an increasing trend towards cost-cutting on medicines, so the debt crisis is pressuring our margins," Dekkers told Tagesspiegel newspaper in a interview released ahead of publication on Monday. "Besides price pressure in HealthCare, demand is weakening for our plastics," he said. Dekkers complained about weak payment discipline in highly indebted euro area countries, especially Greece, Italy and Spain.

Back to news